FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine Notified -
LambdaTest Becomes First Platform to Launch Appium 3 Beta Support for Cloud-Based Mobile Testing Notified -
Teledyne launches Z-Trak Express 1K5 for cost-effective, in-line 3D measurement and inspection Notified -
Axi Brings Their A-Game with Axi Select: Early Access 10% Profit-Sharing Offer Launches This August Notified -